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Barriers to Substance Use Disorder Treatment

Overview
The mission of the University of Vermont Center on Rural Addiction (UVM
CORA) is to expand addiction treatment capacity in rural counties in New
Hampshire, Vermont, Maine, northern New York, and throughout the
country by providing consultation, resources, training, and evidence‐based
technical assistance to healthcare providers and staff. Our New Hampshire
baseline needs assessment, conducted in collaboration with the New
Hampshire Citizens Health Inititative at the University of New Hampshire
Institute for Health Policy and Practice, aimed to identify current and future
substance use disorder (SUD) treatment needs and barriers in rural counties.
This data brief focuses on practitioners’ and community stakeholders’
reported barriers and challenges to treating patients with opioid use
disorder (OUD) and beliefs about treating patients using medications for
OUD (MOUD).

Methods and Sample
From October 2020 to March 2021, we surveyed practitioners and
community stakeholders working across New Hampshire using an online
survey. Respondents included 152 practitioners (81 of whom reported
working in rural counties) and 101 community stakeholders (74 rural) (Figure
1). Among practitioner respondents, 71 (42 rural) were in counseling, case
management, and recovery coach roles, and 81 (39 rural) were in clinician
and pharmacist roles.

Figure 1. New Hampshire practitioner (P) and community
stakeholder (CS) respondents in rural (green) and non‐
rural (grey) counties. This map excludes 19 practitioners
and 12 community stakeholders who reported working in
multiple counties.

Practitioner-related Barriers to Treating Patients with Opioid Use Disorder
Practitioners were asked to report on the barriers they experience in treating patients with OUD in their practices (Figure
2). 55% of New Hampshire practitioners (rural: 57%) identified time and staffing constraints among their top three barriers.
43% of practitioners (rural: 39%) identified organizational and clinical
barriers among their top three barriers to treating patients with OUD.
“I think if our Providers in Primary Care
39% of practitioners (rural: 34%) identified lack of training, and 36%
screened more for opiate abuse, instead of
(rural: 37%) identified stigma of OUD in their top three barriers to
pretending it doesn't exist that would help
treating patients with OUD. Additionally, one in five practitioners
with stigma and help people get the services
(rural:
19%) identified other barriers, such as lack of housing, lack of
they need.”
available counseling or social work support for patients (especially
‐ Rural Practitioner
un‐ and under‐ insured patients), and the availability of affordable
“Limitations in workforce and competing
treatment options. There were no significant differences between
demands are barriers.”
rural and non‐rural practitioners in the top barriers that they
‐ Rural Practitioner
identified to treating patients with OUD in their practices.
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Patient-Related Barriers to Receiving Treatment for Opioid Use Disorder
Practitioners were also asked about their beliefs regarding patient‐related barriers to receiving treatment for OUD (Figure
3). 79% of practitioners (rural: 80%) identified lack of time, transportation, and other supports as a top barrier to patients
receiving treatment. Other frequently identified barriers included stigma of OUD (59%; rural: 65%), concerns about
treatment/health issues (40%; rural: 31%), and insurance or reimbursement issues (39%; rural: 35%). A significantly greater
proportion of rural practitioners (43%) identified parenting and family demands as a top barrier for patients compared to
non‐rural practitioners (22%). Community stakeholders (n=99; 72 rural) were also asked about challenges to
treating patients with OUD in the communities in which they work. Stakeholders identified patient barriers (e.g.,
transportation, time, childcare; 56%; rural: 58%), insufficient capacity to treat patients (42%; rural: 40%), and stigma (40%;
rural: 43%) as the top challenges to treating patients with OUD.

Figure 2. Practitioner‐identified top barriers to treating patients with
opioid use disorder (OUD) (n=149).

Figure 3. Practitioner‐identified top barriers to patients receiving opioid
use disorder (OUD) treatment (n=150).

Beliefs about Medications for Opioid Use Disorder
Practitioners (n=146) and community stakeholders (n=98) reported the extent to
which they agreed with the statement, “Medications (like methadone and
buprenorphine) are the most effective way to treat people with opioid use
disorder” (Figure 4). Only 65% (rural: 59%) of practitioners agreed or strongly
agreed with the statement, and this was significantly higher than the 35% (rural:
36%) of community stakeholders who agreed or strongly agreed. 28% (rural:
37%) of practitioners and 49% (rural: 47%) of community stakeholders neither
agreed nor disagreed. A greater proportion of practitioners in
clinician/pharmacist roles agreed or strongly agreed with the statement (81%; Figure 4. Distribution of agreement among
rural: 81%) than practitioners in counselor/case manager roles (48%; rural: 39%). practitioners (n=146) and community stakeholders
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(n=98) with the statement “Medications (like
methadone and buprenorphine) are the most effective
way to treat people with opioid use disorder.”

Please visit uvmcora.org to find more information about our baseline needs
assessments in New Hampshire, Vermont, Maine, and northern New York, as well as resources and technical assistance on
SUD treatment.
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